AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Osteoarthritis Market (2021 to 2025) - Insights, Trends & Forecasts - ResearchAndMarkets.com

June 25, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jun 25, 2021--

The “Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)” report has been added to ResearchAndMarkets.com’s offering.

The global osteoarthritis market revenues are forecasted to touch US$10.92 billion in 2025, growing at a CAGR of 9.85% for the period spanning from 2021 to 2025.

Factors such as the increasing occurrence of osteoarthritis, the growing geriatric population, rising healthcare expenditure per capita, the growing obese population, and improving consumer confidence index are expected to drive the market growth. However, the growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

ADVERTISEMENT

In 2020, the outbreak of the COVID-19 pandemic has created an unfavorable impact on the market as osteoarthritis therapeutics sales declined during Q1-2020.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to the growth in the prevalence of joint disorders across the world.

The fastest-growing regional market is North America. The growth was supported by growth in the geriatric population, the surge in HA injections demand, rise in sports injuries and development in the e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels

Companies Mentioned

  • Bayer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

Scope of the report:

  • The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.

Key Topics Covered:

1. Market Overview

ADVERTISEMENT

2. Global Osteoarthritis Market Analysis
2.1 Global Osteoarthritis Market Value
2.2 Global Osteoarthritis Market Value Forecast
2.3 Global Osteoarthritis Market Value by Anatomy Type
2.3.1 Global Knee Osteoarthritis Market Value
2.3.2 Global Knee Osteoarthritis Market Value Forecast
2.3.3 Global Knee Osteoarthritis Market Value by Region
2.4 Global Osteoarthritis Market Value by Treatment Type
2.4.1 Global Osteoarthritis IA Injections Market Value
2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
2.4.3 Global Osteoarthritis Drugs Market Value
2.4.4 Global Osteoarthritis Drugs Market Value Forecast
2.4.5 Global Osteoarthritis Drugs Market Value by Type
2.4.6 Global Osteoarthritis NSAIDs Market Value
2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
2.4.8 Global Osteoarthritis Analgesics Market Value
2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
2.4.13 Global Osteoarthritis Oral Drugs Market Value
2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
2.5 Global Osteoarthritis Market Value by Distribution Channels
2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis
3.1 North America
3.2 Europe
3.3 Asia-Pacific

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Inclining Occurrence of Osteoarthritis
4.1.2 Growing Geriatric Population
4.1.3 Rising Healthcare Expenditure per Capita
4.1.4 Growing Obese Population
4.1.5 Improving Consumer Confidence Index
4.2 Key Trends and Developments
4.2.1 Growth in Pharmaceutical R&D Expenditures
4.2.2 Progressing Product Pipeline
4.2.3 Advancement in Osteoarthritis Treatments
4.2.4 Growth in Online Pharmaceutical Sales
4.3 Challenges
4.3.1 Associated Business Risk
4.3.2 Patient Health-Associated Risk
4.3.3 Stringent Regulations

5. Competitive Landscape
5.1 Global Osteoarthritis Market
5.1.1 Key Players - Revenues Comparison
5.1.2 Key Players - Market Cap Comparison
5.1.3 Key Players - R&D Expenditures Comparison

6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/qrmuq0

View source version on businesswire.com:https://www.businesswire.com/news/home/20210625005354/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 06/25/2021 11:22 AM/DISC: 06/25/2021 11:22 AM

http://www.businesswire.com/news/home/20210625005354/en